The Sleep Apnea Breakthrough FDA Approval for Sleep Apnea In December 2024, the FDA made history by approving tirzepatide (Zepbound) as the first medication specifically for treating obstructive sleep apnea in adults with obesity
If you are in crisis or find yourself needing more support please call the UToledo Counseling Center Care Line at 419-530-2273 (CARE) or dial 9-1-1 if it is an emergency.
"It brings up a bigger understanding of obesity as a condition rather than an individual or moral failure," he said
If your pharmacy lists a price thats too high for comfort, try searching your GLP-1 medication on a site like GoodRx, which scours pharmacies and finds coupons to present you with the cheapest options
Common side effects include low blood sugar, nausea, diarrhea, and headaches
Common brand names for GLP-1 drugs include Wegovy, Ozempic, Mounjaro and Saxenda